Skip to content
IP Osgoode
  • ABOUT
  • OUR TEAM
    • DIRECTOR
    • MEMBERS
    • ADVISORY BOARD
    • SPONSORS
  • IPILOGUE
    • BLOG
    • IPILOGUE EDITORS
    • GOWLING WLG PRIZE
    • IPIGRAM ARCHIVE
  • INNOVATION CLINIC
    • ABOUT
    • CHATBOT
    • BECOME A CLIENT
    • CLINIC FELLOWS
    • FAQS
  • IP INTENSIVE
    • ABOUT
    • PLACEMENTS
  • RESEARCH
    • IP LAW & POLICY
    • INNOVATION
    • LAW REFORM
  • EVENTS
    • UPCOMING EVENTS
    • PAST EVENTS
  • OTHER ACTIVITIES
    • IP WRITING CHALLENGE
    Home
    >
    IP
    >
    Patents
    >
    Access to Medicines

    Category: Access to Medicines

    August 16, 2017in Access to Medicines, Blogs, Commercialization, Development, Innovation, Patentability, Patents, Pharmaceutical Drugs, Uncategorized0by Editor
    682

    Broken Promises: Utility Standards and Patent Applications in Canada

    The last day of June 2017 saw the Supreme Court of Canada (SCC) quash the controversial Promise Doctrine. The issue at hand in AstraZeneca Canada Inc v Apotex Inc was…

    Read more
    January 11, 2017in Access to Medicines, Commercialization, Design, Development, IP, Patentability, Patents, Pharmaceutical Drugs, Uncategorized0by Editor
    927

    What Makes It My Molecule: A Look at Professor Ronald Pearlman’s Genome Editing Work

    This past November, Professor Ronald E. Pearlman from York University’s Department of Biology gave a talk [1] at Osgoode Hall Law School to discuss the potential of the innovative CRISPR…

    Read more
    May 21, 2015in Access to Medicines, Patents, Pharmaceutical Drugs0by Editor
    264

    Breaking the Fall Off the Patent Cliff: Can Developing Countries Help Big Pharma?

    Expiring patents are expected to contribute billions of dollars towards the loss of revenue of drug manufacturers in the years to come. To save itself from falling off the patent cliff,…

    Read more
    April 1, 2015in Access to Medicines, Cross Border Issues, Feature Post, IP, Patents0by Editor
    551

    Virotech Patents, Viropiracy, and Viral Sovereignty

    INTRODUCTION Access to medicines goes hand in hand with the protection of intellectual property rights. At a time when the United States is undertaking large-scale reforms in both the intellectual…

    Read more
    March 25, 2014in Access to Medicines, Human Rights, Human Rights Issues, Innovation, Internet, IP, Social Justice, Tech Transfer, Technology0by Editor
    666

    The Future of Rights: Intellectual Property, Economic Inequality and the ‘Digital Divide’

    A quarter century since he helped to create it, the man widely regarded as the creator of the World Wide Web, Tim Berners-Lee, has renewed calls for a Digital Bill…

    Read more
    November 12, 2013in Access to Medicines, Blogs, Canada, Cross Border Issues, IP, IP Reform, Jurisdiction, Patents, Pharmaceutical Drugs, Regulatory Policy, Trademarks0by Editor
    364

    Canada’s IP Laws and the Comprehensive Economic and Trade Agreement (CETA): Canada Got the Short End of the Proverbial Stick

    The outline of CETA has arrived – but its full text is still in transit. On what we know of the intellectual property aspects of CETA, Canada got the short…

    Read more

    Posts navigation

    1 2 … 5
    Search
      Categories
      IP Osgoode
      © Osgoode Hall Law School, York University
      • Privacy & Legal
      Osgoode Hall Law School, York University
      Ignat Kaneff Building
      4700 Keele Street
      Toronto, Ontario  M3J 1P3
      Canada

      T:416.736.5030   F:416.736.5736